Clinical Nurse Specialist, Psychiatric/Mental Health · Toms River, NJ
NPI
1851308522
Since 2006
Specialty
Clinical Nurse Specialist, Psychiatric/Mental Health
Code 364SP0808X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1691 Highway 9, Cn 2025
Toms River, NJ, 08754
Phone (732) 914-3843
Groups this clinician bills Medicare through
Medicare paid, 2022
$5,087
71 services
Medicare patients, 2022
12
Average age 60
Drug cost, 2024
$1.8M
3,656 prescriptions
Company payments, 2025
$1,383
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Audrey L Kelly prescribed most often to Medicare patients was Olanzapine, with 202 prescriptions and refills. In total Audrey L Kelly wrote 3,656 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Olanzapine Generic | 202 | 232 | 19 | $3,627 |
| Fluoxetine Hcl Generic | 168 | 186 | 13 | $1,949 |
| Clonazepam Generic | 160 | 175 | 18 | $1,082 |
| Trazodone Hcl Generic | 148 | 156 | 19 | $1,188 |
| Gabapentin Generic | 143 | 143 | 17 | $2,530 |
| Lamotrigine Generic | 140 | 164 | 13 | $1,018 |
| Invega Sustenna Paliperidone Palmitate | 124 | 133 | 14 | $389K |
| Risperidone Generic | 117 | 119 | 12 | $896 |
| Sertraline Hcl Generic | 113 | 125 | 11 | $1,105 |
| Prazosin Hcl Generic | 110 | 122 | 16 | $2,452 |
| Duloxetine Hcl Generic | 98 | 108 | Under 11 | $849 |
| Bupropion Xl Bupropion Hcl | 94 | 112 | 14 | $1,279 |
| Metformin Hcl Generic | 90 | 100 | 14 | $416 |
| Doxepin Hcl Generic | 90 | 106 | 11 | $3,254 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 76 | 82 | Under 11 | $672 |
Brand drugs: 761 claims; generic drugs: 2,895 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Audrey L Kelly $1,383 ($1,383 in general payments such as food, travel and fees) from 9 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $580.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 21 | $580 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $170 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $163 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $162 |
| Alkermes, Inc. ALKS | 3 | $158 |
| Abbvie Inc. ABBV | 4 | $61.22 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $39.81 |
| Axsome Therapeutics, Inc. AXSM | 2 | $31.99 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $17.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.